NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced results of a well ...
An overview of how disease-modifying treatments for Alzheimer disease can impact medical costs and caregiver burden. Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback